Nov 13, 2024 / 01:00PM GMT
Operator
Good day and welcome to the AR S Pharmaceuticals third quarter, 2024 conference call. At this time, all participants are in listen-only mode after the speakers' presentation, there'll be a question-and-answer session instructions will be given at that time. As a reminder, this call may be recorded. I would now like to turn the call over to Alex Tro ofs. Please go ahead.
Unidentified_2
Good morning and thank you for joining with me on the call. Today are Richard Lowenthal, co founder, President and CEO of AR S Eric Karra, our Chief Commercial Officer Kathy Scott, our CFO and Justin Chakma, our Chief Business Officer.
Earlier today, we issued a press release detailing our third quarter, 2024 results and recent business highlights which can be found on our website at A S dash pharma dotcom.
For today's call rich will provide an overview of our recent corporate developments.
Eric will provide an update on our nepi commercialization efforts. Kathy will provide a brief overview of our financial results and the full team will join us for Q&A
Q3 2024 ARS Pharmaceuticals Inc Earnings Call Transcript
Nov 13, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers